MX390682B - Vacunas que contienen patogenos de cerdo para uso no mixto asociado. - Google Patents
Vacunas que contienen patogenos de cerdo para uso no mixto asociado.Info
- Publication number
- MX390682B MX390682B MX2019012220A MX2019012220A MX390682B MX 390682 B MX390682 B MX 390682B MX 2019012220 A MX2019012220 A MX 2019012220A MX 2019012220 A MX2019012220 A MX 2019012220A MX 390682 B MX390682 B MX 390682B
- Authority
- MX
- Mexico
- Prior art keywords
- vaccine
- infection
- virus
- vaccines containing
- swine pathogens
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 7
- 241000282898 Sus scrofa Species 0.000 title 1
- 244000052769 pathogen Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 abstract 3
- 241001673669 Porcine circovirus 2 Species 0.000 abstract 3
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 230000003362 replicative effect Effects 0.000 abstract 2
- 230000002238 attenuated effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17166590 | 2017-04-13 | ||
| PCT/EP2018/059389 WO2018189290A1 (en) | 2017-04-13 | 2018-04-12 | Vaccines containing swine pathogens for associated non-mixed use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019012220A MX2019012220A (es) | 2019-12-09 |
| MX390682B true MX390682B (es) | 2025-03-21 |
Family
ID=58547447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019012220A MX390682B (es) | 2017-04-13 | 2018-04-12 | Vacunas que contienen patogenos de cerdo para uso no mixto asociado. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11311614B2 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4335455A3 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7665289B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR102724420B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN110446502B (cg-RX-API-DMAC10.html) |
| CA (1) | CA3058281A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MX390682B (cg-RX-API-DMAC10.html) |
| RU (1) | RU2756767C2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018189290A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3058281A1 (en) * | 2017-04-13 | 2018-10-18 | Intervet International B.V. | Vaccines containing swine pathogens for associated non-mixed use |
| MX2022013080A (es) * | 2020-04-20 | 2022-11-10 | Intervet Int Bv | Una combinacion de vacunas para el tratamiento profilactico de un cerdo. |
| US20230241198A1 (en) * | 2020-07-24 | 2023-08-03 | Boehringer Ingelheim Animal Health USA Inc. | Combination porcine vaccine |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6042830A (en) * | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
| WO2002026250A2 (en) * | 2000-09-29 | 2002-04-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Vaccines for proliferative ileitis |
| CA2587321A1 (en) | 2005-01-13 | 2006-07-20 | Boehringer Ingelheim Vetmedica Gmbh | Improved prrs vaccines |
| CN101277717A (zh) | 2005-09-09 | 2008-10-01 | 英特威国际有限公司 | Pcv-2疫苗 |
| CA2635430A1 (en) | 2005-12-29 | 2007-08-23 | Boehringer Ingelheim Vetmedica, Inc. | Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| PT2094872T (pt) | 2006-12-15 | 2017-04-27 | Boehringer Ingelheim Vetmedica Inc | Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2 |
| TWI449533B (zh) * | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗 |
| US8728487B2 (en) | 2011-01-20 | 2014-05-20 | Hua Wu | Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome |
| UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
| UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| US9457073B2 (en) | 2012-09-26 | 2016-10-04 | University Of Manitoba | Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity |
| WO2015082457A1 (en) | 2013-12-03 | 2015-06-11 | Intervet International B.V. | Vaccine against lawsonia intracellularis and porcine circovirus 2 |
| PL3076996T3 (pl) * | 2013-12-03 | 2020-05-18 | Intervet International B.V. | Szczepionka przeciwko cirkowirusowi świń typu 2 |
| KR102360690B1 (ko) | 2013-12-03 | 2022-02-08 | 인터벳 인터내셔널 비.브이. | Ｐｒｒｓ 및 로소니아 인트라셀룰라리스에 대한 돼지 백신 |
| US20200023128A1 (en) * | 2016-12-22 | 2020-01-23 | Intervet Inc. | Needleless injector |
| CA3058281A1 (en) * | 2017-04-13 | 2018-10-18 | Intervet International B.V. | Vaccines containing swine pathogens for associated non-mixed use |
-
2018
- 2018-04-12 CA CA3058281A patent/CA3058281A1/en active Pending
- 2018-04-12 CN CN201880022778.9A patent/CN110446502B/zh active Active
- 2018-04-12 EP EP23217834.3A patent/EP4335455A3/en active Pending
- 2018-04-12 RU RU2019136252A patent/RU2756767C2/ru active
- 2018-04-12 US US16/604,188 patent/US11311614B2/en active Active
- 2018-04-12 MX MX2019012220A patent/MX390682B/es unknown
- 2018-04-12 KR KR1020197029516A patent/KR102724420B1/ko active Active
- 2018-04-12 JP JP2019555621A patent/JP7665289B2/ja active Active
- 2018-04-12 WO PCT/EP2018/059389 patent/WO2018189290A1/en not_active Ceased
- 2018-04-12 EP EP18719484.0A patent/EP3609533A1/en not_active Ceased
-
2022
- 2022-12-06 JP JP2022194985A patent/JP2023025210A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP4335455A2 (en) | 2024-03-13 |
| KR102724420B1 (ko) | 2024-10-30 |
| RU2756767C2 (ru) | 2021-10-05 |
| JP2020513027A (ja) | 2020-04-30 |
| MX2019012220A (es) | 2019-12-09 |
| EP4335455A3 (en) | 2024-05-22 |
| JP7665289B2 (ja) | 2025-04-21 |
| CA3058281A1 (en) | 2018-10-18 |
| CN110446502B (zh) | 2024-01-26 |
| RU2019136252A (ru) | 2021-05-13 |
| WO2018189290A1 (en) | 2018-10-18 |
| RU2019136252A3 (cg-RX-API-DMAC10.html) | 2021-05-13 |
| JP2023025210A (ja) | 2023-02-21 |
| US20200046825A1 (en) | 2020-02-13 |
| CN110446502A (zh) | 2019-11-12 |
| EP3609533A1 (en) | 2020-02-19 |
| US11311614B2 (en) | 2022-04-26 |
| KR20190134650A (ko) | 2019-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX388128B (es) | Vacuna combinada para cerdos. | |
| PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
| CO6361948A2 (es) | Uso de antigeno de mycoplasma bovis | |
| AR057586A1 (es) | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina | |
| RU2018137034A (ru) | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae | |
| BR112018010679A8 (pt) | métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina | |
| PH12018501368A1 (en) | M hyo multivalent vaccine and uses thereof | |
| MX2022003090A (es) | Vacuna combinada para ser administrable intradermicamente. | |
| MX2019012220A (es) | Vacunas que contienen patogenos de cerdo para uso no mixto asociado. | |
| MX2020006662A (es) | Vacuna combinada intradermica contra mycoplasma y circovirus porcino. | |
| MX371126B (es) | Vacuna para cerdos contra el sindrome reproductivo y respiratorio porcino y lawsonia intracellularis. | |
| MX2016007225A (es) | Vacuna contra lawsonia intracellularis y circovirus porcino 2. | |
| CL2023002187A1 (es) | Virus para vacuna contra el síndrome respiratorio y reproductivo porcino | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| BR112022019207A2 (pt) | Composições de vacina para coronavírus e métodos de uso das mesmas | |
| MX2022013080A (es) | Una combinacion de vacunas para el tratamiento profilactico de un cerdo. | |
| MX2020006061A (es) | Una vacuna para proteccion contra streptococcus suis. | |
| BR112018069193A2 (pt) | uma vacina de combinação contra infecção por vírus pcv2 e prrs compreendendo albumina | |
| ECSP21039816A (es) | Anticuerpos monoclonales antirrábicos y cóctel de estos | |
| MX2019001395A (es) | Clon de adnc del virus del sindrome reproductivo y respiratorio porcino y usos del mismo. | |
| BR112018069219A2 (pt) | uma vacina para aplicação intradérmica contra infecção pelo vírus pcv2 e prrs | |
| UA122732U (uk) | Вакцина проти репродуктивно-респіраторного синдрому цирковірусної та парвовірусної інфекції свиней асоційована інактивована емульсована | |
| JP2019512518A5 (cg-RX-API-DMAC10.html) | ||
| TH1801003840A (th) | วัคซีนเอ็ม ไฮโอ มัลติวาเลนท์ และการใช้ของมัน | |
| TH1901006532A (th) | วัคซีนซึ่งมีเชื้อก่อโรคในสุกรเพื่อการใช้ที่เกี่ยวเนื่องแบบไม่ผสมกัน |